Condition: Immune Thrombocytopenic Purpura (ITP) · Sponsor: Takeda
Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it easier to bruise or bleed. The main aim of this study is to learn whether mezagitamab, when given just under the skin (subcutaneously \[SC\]), is effective in keeping the platelet count of adults with ITP stable when compared to a placebo. A placebo looks like medicine but doesn't have any active ingredients in it. The participants will be treated with mezagitamab for up to 6 months. During the study, participants will visit their study clinic several times. Participants who complete the TAK-079-3002 study or do not have any response to study treatment by week 16 (according to study criteria) will be given the opportunity to participate in a continuation study to receive open label mezagitamab (if they are eligible and the site is able to open the continuation study).
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| USC Norris Comprehensive Cancer Center - Keck Medicine of USC | Los Angeles, California, United States | Recruiting |
| Rocky Mountain Cancer Center | Denver, Colorado, United States | Withdrawn |
| Georgetown University Medical Center - Lombardi Comprehensive Cancer Center | Washington D.C., District of Columbia, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| The University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University Of Louisville Brown Cancer Center | Louisville, Kentucky, United States | Recruiting |
| American Oncology Partners of Maryland, PA | Bethesda, Maryland, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Massachusetts Chan Medical School | Worcester, Massachusetts, United States | Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Recruiting |
| East Carolina University | Greenville, North Carolina, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
+ 102 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06722235